172 related articles for article (PubMed ID: 26797281)
1. The role of NUB1 in α-synuclein degradation in Lewy body disease model mice.
Tanji K; Miki Y; Maruyama A; Mori F; Mimura J; Itoh K; Kamitani T; Wakabayashi K
Biochem Biophys Res Commun; 2016 Feb; 470(3):635-642. PubMed ID: 26797281
[TBL] [Abstract][Full Text] [Related]
2. Synphilin-1-binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant α-synuclein in presynapses in Lewy body disease.
Tanji K; Mori F; Kito K; Kakita A; Mimura J; Itoh K; Takahashi H; Kamitani T; Wakabayashi K
J Neuropathol Exp Neurol; 2011 Oct; 70(10):879-89. PubMed ID: 21937912
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated NUB1 distinguishes α-synuclein in Lewy bodies from that in glial cytoplasmic inclusions in multiple system atrophy.
Tanji K; Miki Y; Mori F; Kon T; Kakita A; Takahashi H; Wakabayashi K
Brain Pathol; 2019 Nov; 29(6):803-812. PubMed ID: 31006160
[TBL] [Abstract][Full Text] [Related]
4. Trehalose intake induces chaperone molecules along with autophagy in a mouse model of Lewy body disease.
Tanji K; Miki Y; Maruyama A; Mimura J; Matsumiya T; Mori F; Imaizumi T; Itoh K; Wakabayashi K
Biochem Biophys Res Commun; 2015 Oct; 465(4):746-52. PubMed ID: 26299928
[TBL] [Abstract][Full Text] [Related]
5. Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice.
Tanji K; Mori F; Mimura J; Itoh K; Kakita A; Takahashi H; Wakabayashi K
Acta Neuropathol; 2010 Aug; 120(2):145-54. PubMed ID: 20339856
[TBL] [Abstract][Full Text] [Related]
6. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein.
Bernis ME; Babila JT; Breid S; Wüsten KA; Wüllner U; Tamgüney G
Acta Neuropathol Commun; 2015 Nov; 3():75. PubMed ID: 26612754
[TBL] [Abstract][Full Text] [Related]
7. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
[TBL] [Abstract][Full Text] [Related]
8. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.
Yan R; Zhang J; Park HJ; Park ES; Oh S; Zheng H; Junn E; Voronkov M; Stock JB; Mouradian MM
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E12053-E12062. PubMed ID: 30509990
[TBL] [Abstract][Full Text] [Related]
9. p62 Deficiency Enhances α-Synuclein Pathology in Mice.
Tanji K; Odagiri S; Miki Y; Maruyama A; Nikaido Y; Mimura J; Mori F; Warabi E; Yanagawa T; Ueno S; Itoh K; Wakabayashi K
Brain Pathol; 2015 Sep; 25(5):552-64. PubMed ID: 25412696
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders.
Tanji K; Mori F; Kakita A; Zhang H; Kito K; Kamitani T; Takahashi H; Wakabayashi K
Acta Neuropathol; 2007 Oct; 114(4):365-71. PubMed ID: 17549501
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
Rockenstein E; Nuber S; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Trejo-Morales M; Gerez J; Picotti P; Jensen PH; Campioni S; Riek R; Winkler J; Gage FH; Winner B; Masliah E
Brain; 2014 May; 137(Pt 5):1496-513. PubMed ID: 24662516
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease.
Zhou W; Milder JB; Freed CR
J Biol Chem; 2008 Apr; 283(15):9863-70. PubMed ID: 18238775
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein aggregates are excluded from calbindin-D28k-positive neurons in dementia with Lewy bodies and a unilateral rotenone mouse model.
Rcom-H'cheo-Gauthier AN; Davis A; Meedeniya ACB; Pountney DL
Mol Cell Neurosci; 2016 Dec; 77():65-75. PubMed ID: 27746320
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
Klucken J; Ingelsson M; Shin Y; Irizarry MC; Hedley-Whyte ET; Frosch M; Growdon J; McLean P; Hyman BT
Acta Neuropathol; 2006 Feb; 111(2):101-8. PubMed ID: 16482476
[TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models.
Iba M; Kim C; Sallin M; Kwon S; Verma A; Overk C; Rissman RA; Sen R; Sen JM; Masliah E
J Neuroinflammation; 2020 Jul; 17(1):214. PubMed ID: 32680537
[TBL] [Abstract][Full Text] [Related]
16. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.
Crews L; Spencer B; Desplats P; Patrick C; Paulino A; Rockenstein E; Hansen L; Adame A; Galasko D; Masliah E
PLoS One; 2010 Feb; 5(2):e9313. PubMed ID: 20174468
[TBL] [Abstract][Full Text] [Related]
17. Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model.
Kahle PJ; Neumann M; Ozmen L; Müller V; Odoy S; Okamoto N; Jacobsen H; Iwatsubo T; Trojanowski JQ; Takahashi H; Wakabayashi K; Bogdanovic N; Riederer P; Kretzschmar HA; Haass C
Am J Pathol; 2001 Dec; 159(6):2215-25. PubMed ID: 11733371
[TBL] [Abstract][Full Text] [Related]
18. An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model.
Hashimoto M; Rockenstein E; Mante M; Crews L; Bar-On P; Gage FH; Marr R; Masliah E
Gene Ther; 2004 Dec; 11(23):1713-23. PubMed ID: 15483670
[TBL] [Abstract][Full Text] [Related]
19. NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1.
Tanji K; Tanaka T; Mori F; Kito K; Takahashi H; Wakabayashi K; Kamitani T
Am J Pathol; 2006 Aug; 169(2):553-65. PubMed ID: 16877356
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5--implications for dementia with Lewy bodies.
Overk CR; Cartier A; Shaked G; Rockenstein E; Ubhi K; Spencer B; Price DL; Patrick C; Desplats P; Masliah E
Mol Neurodegener; 2014 May; 9():18. PubMed ID: 24885390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]